~67% eye preservation rate (6 of 9 enucleation patients) with darovasertib monotherapy neoadjuvant uveal melanoma treatment Median tumor shrinkage (maximum volume change) of ~45% after 6 months Clinical data on additional enucleation patients and with further follow-up from the…